{"entity":{"type":"insider","cik":"0001399028","url":"/insider/0001399028","json_url":"/insider/0001399028.json","name":"Vivo Ventures V, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":61,"n_filings":20,"first":"2013-05-20","last":"2019-12-03","span_basis":"filed_date"},"name_variants":[{"name":"Vivo Ventures V, LLC","source":"filing","n_filings":20,"first_seen":"2013-05-20","last_seen":"2019-12-03"}],"transactions":[{"id":8301130,"accession":"0001213900-19-025237","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-025237","line_url":"/filing/0001213900-19-025237#line-1","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures V Affiliates Fund, L.P.; Vivo Ventures Fund V, L.P.; Vivo Ventures V, LLC","owner_display_name":"Vivo Ventures V Affiliates Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34028.0,"shares_display":"34,028","price_per_share":1.62,"price_display":"1.62","price_state":"stated","total_value":55125.36,"total_display":"55,125.36","total_whole":"55,125","shares_owned_after":3633805.0,"shares_owned_after_display":"3,633,805","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-03","scope":"insider"},{"id":7880132,"accession":"0001213900-19-024996","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-19-024996","line_url":"/filing/0001213900-19-024996#line-2","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures Fund V, L.P.; Vivo Ventures V, LLC; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2898.0,"shares_display":"2,898","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":4433.94,"total_display":"4,433.94","total_whole":"4,434","shares_owned_after":3667833.0,"shares_owned_after_display":"3,667,833","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-27","filed_date":"2019-11-27","scope":"insider"},{"id":7880125,"accession":"0001213900-19-024996","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-024996","line_url":"/filing/0001213900-19-024996#line-1","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures Fund V, L.P.; Vivo Ventures V, LLC; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15171.0,"shares_display":"15,171","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":23515.05,"total_display":"23,515.05","total_whole":"23,515","shares_owned_after":3670731.0,"shares_owned_after_display":"3,670,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-27","scope":"insider"},{"id":8602056,"accession":"0001213900-19-024649","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-19-024649","line_url":"/filing/0001213900-19-024649#line-3","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures V Affiliates Fund, L.P.; Vivo Ventures V, LLC; Vivo Ventures Fund V, L.P.","owner_display_name":"Vivo Ventures V Affiliates Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14775.0,"shares_display":"14,775","price_per_share":1.56,"price_display":"1.56","price_state":"stated","total_value":23049.0,"total_display":"23,049.00","total_whole":"23,049","shares_owned_after":3685902.0,"shares_owned_after_display":"3,685,902","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-25","filed_date":"2019-11-25","scope":"insider"},{"id":8602054,"accession":"0001213900-19-024649","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-19-024649","line_url":"/filing/0001213900-19-024649#line-2","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures V Affiliates Fund, L.P.; Vivo Ventures V, LLC; Vivo Ventures Fund V, L.P.","owner_display_name":"Vivo Ventures V Affiliates Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":4030.0,"total_display":"4,030.00","total_whole":"4,030","shares_owned_after":3700677.0,"shares_owned_after_display":"3,700,677","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-22","filed_date":"2019-11-25","scope":"insider"},{"id":8602051,"accession":"0001213900-19-024649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-024649","line_url":"/filing/0001213900-19-024649#line-1","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures V Affiliates Fund, L.P.; Vivo Ventures V, LLC; Vivo Ventures Fund V, L.P.","owner_display_name":"Vivo Ventures V Affiliates Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44296.0,"shares_display":"44,296","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":68658.8,"total_display":"68,658.80","total_whole":"68,659","shares_owned_after":3703277.0,"shares_owned_after_display":"3,703,277","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-21","filed_date":"2019-11-25","scope":"insider"},{"id":7880122,"accession":"0001213900-19-024233","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-19-024233","line_url":"/filing/0001213900-19-024233#line-3","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures Fund V, L.P.; Vivo Ventures V, LLC; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40929.0,"shares_display":"40,929","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":63439.95,"total_display":"63,439.95","total_whole":"63,440","shares_owned_after":3747573.0,"shares_owned_after_display":"3,747,573","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-20","filed_date":"2019-11-20","scope":"insider"},{"id":7880119,"accession":"0001213900-19-024233","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-19-024233","line_url":"/filing/0001213900-19-024233#line-2","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures Fund V, L.P.; Vivo Ventures V, LLC; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":930.0,"total_display":"930.00","total_whole":"930","shares_owned_after":3788502.0,"shares_owned_after_display":"3,788,502","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-19","filed_date":"2019-11-20","scope":"insider"},{"id":7880115,"accession":"0001213900-19-024233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-024233","line_url":"/filing/0001213900-19-024233#line-1","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures Fund V, L.P.; Vivo Ventures V, LLC; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":155.0,"total_display":"155.00","total_whole":"155","shares_owned_after":3789102.0,"shares_owned_after_display":"3,789,102","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-20","scope":"insider"},{"id":8521333,"accession":"0001213900-19-023778","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-19-023778","line_url":"/filing/0001213900-19-023778#line-3","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures V, LLC; Vivo Ventures V Affiliates Fund, L.P.; Vivo Ventures Fund V, L.P.","owner_display_name":"Vivo Ventures V, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51404.0,"shares_display":"51,404","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":79676.2,"total_display":"79,676.20","total_whole":"79,676","shares_owned_after":3789202.0,"shares_owned_after_display":"3,789,202","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-15","scope":"insider"},{"id":8521329,"accession":"0001213900-19-023778","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-19-023778","line_url":"/filing/0001213900-19-023778#line-2","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures V, LLC; Vivo Ventures V Affiliates Fund, L.P.; Vivo Ventures Fund V, L.P.","owner_display_name":"Vivo Ventures V, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31391.0,"shares_display":"31,391","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":48656.05,"total_display":"48,656.05","total_whole":"48,656","shares_owned_after":3840606.0,"shares_owned_after_display":"3,840,606","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-14","filed_date":"2019-11-15","scope":"insider"},{"id":8521325,"accession":"0001213900-19-023778","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-023778","line_url":"/filing/0001213900-19-023778#line-1","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures V, LLC; Vivo Ventures V Affiliates Fund, L.P.; Vivo Ventures Fund V, L.P.","owner_display_name":"Vivo Ventures V, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14229.0,"shares_display":"14,229","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":22054.95,"total_display":"22,054.95","total_whole":"22,055","shares_owned_after":3871997.0,"shares_owned_after_display":"3,871,997","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-13","filed_date":"2019-11-15","scope":"insider"},{"id":8169887,"accession":"0001213900-19-022412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-022412","line_url":"/filing/0001213900-19-022412#line-1","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures V Affiliates Fund, L.P.; Vivo Ventures V, LLC; Vivo Ventures Fund V, L.P.","owner_display_name":"Vivo Ventures V Affiliates Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8764.0,"shares_display":"8,764","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":13584.2,"total_display":"13,584.20","total_whole":"13,584","shares_owned_after":3886226.0,"shares_owned_after_display":"3,886,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-05","filed_date":"2019-11-07","scope":"insider"},{"id":8011759,"accession":"0001213900-19-021959","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-19-021959","line_url":"/filing/0001213900-19-021959#line-3","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; Vivo Ventures V, LLC","owner_display_name":"Vivo Ventures Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":214682.0,"shares_display":"214,682","price_per_share":1.58,"price_display":"1.58","price_state":"stated","total_value":339197.56,"total_display":"339,197.56","total_whole":"339,198","shares_owned_after":3894990.0,"shares_owned_after_display":"3,894,990","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-04","filed_date":"2019-11-04","scope":"insider"},{"id":8011757,"accession":"0001213900-19-021959","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-19-021959","line_url":"/filing/0001213900-19-021959#line-2","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; Vivo Ventures V, LLC","owner_display_name":"Vivo Ventures Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94911.0,"shares_display":"94,911","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":147112.05,"total_display":"147,112.05","total_whole":"147,112","shares_owned_after":4109672.0,"shares_owned_after_display":"4,109,672","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-01","filed_date":"2019-11-04","scope":"insider"},{"id":8011753,"accession":"0001213900-19-021959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-021959","line_url":"/filing/0001213900-19-021959#line-1","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; Vivo Ventures V, LLC","owner_display_name":"Vivo Ventures Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24824.0,"shares_display":"24,824","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":38477.2,"total_display":"38,477.20","total_whole":"38,477","shares_owned_after":4204583.0,"shares_owned_after_display":"4,204,583","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-31","filed_date":"2019-11-04","scope":"insider"},{"id":8397926,"accession":"0001213900-19-021314","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-19-021314","line_url":"/filing/0001213900-19-021314#line-2","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures V, LLC; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures V, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7225.0,"shares_display":"7,225","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":11198.75,"total_display":"11,198.75","total_whole":"11,199","shares_owned_after":4229407.0,"shares_owned_after_display":"4,229,407","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-28","filed_date":"2019-10-28","scope":"insider"},{"id":8397921,"accession":"0001213900-19-021314","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-021314","line_url":"/filing/0001213900-19-021314#line-1","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures V, LLC; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures V, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23322.0,"shares_display":"23,322","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":37315.2,"total_display":"37,315.20","total_whole":"37,315","shares_owned_after":4236632.0,"shares_owned_after_display":"4,236,632","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-24","filed_date":"2019-10-28","scope":"insider"},{"id":5237771,"accession":"0000899243-17-029263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-029263","line_url":"/filing/0000899243-17-029263","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures V, LLC; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures V, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1085480.0,"shares_display":"1,085,480","price_per_share":1.8425,"price_display":"1.84","price_state":"stated","total_value":1999996.9,"total_display":"1,999,996.90","total_whole":"1,999,997","shares_owned_after":3888137.0,"shares_owned_after_display":"3,888,137","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-15","filed_date":"2017-12-19","scope":"insider","n_lines":2},{"id":4297207,"accession":"0000899243-17-007102","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-17-007102","line_url":"/filing/0000899243-17-007102#line-6","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures Fund V, L.P.; Vivo Ventures V, LLC; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1394158.0,"shares_display":"1,394,158","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":1338391.68,"total_display":"1,338,391.68","total_whole":"1,338,392","shares_owned_after":14076263.0,"shares_owned_after_display":"14,076,263","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-07","filed_date":"2017-03-09","scope":"insider"},{"id":4297202,"accession":"0000899243-17-007102","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-17-007102","line_url":"/filing/0000899243-17-007102#line-5","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures Fund V, L.P.; Vivo Ventures V, LLC; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76850.0,"shares_display":"76,850","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":12682105.0,"shares_owned_after_display":"12,682,105","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-07","filed_date":"2017-03-09","scope":"insider"},{"id":4297197,"accession":"0000899243-17-007102","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-17-007102","line_url":"/filing/0000899243-17-007102#line-4","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures Fund V, L.P.; Vivo Ventures V, LLC; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16303.0,"shares_display":"16,303","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":15650.88,"total_display":"15,650.88","total_whole":"15,651","shares_owned_after":165372.0,"shares_owned_after_display":"165,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-07","filed_date":"2017-03-09","scope":"insider"},{"id":4297192,"accession":"0000899243-17-007102","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-007102","line_url":"/filing/0000899243-17-007102#line-3","is_derivative":false,"issuer_cik":"0001398936","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001398936","owner_cik":null,"owner_name":"Vivo Ventures Fund V, L.P.; Vivo Ventures V, LLC; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":902.0,"shares_display":"902","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":149069.0,"shares_owned_after_display":"149,069","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-07","filed_date":"2017-03-09","scope":"insider"},{"id":2417310,"accession":"0000904454-16-001183","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001183","line_url":"/filing/0000904454-16-001183","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"Vivo Ventures V, LLC; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures V, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2005.0,"shares_display":"2,005","price_per_share":13.55,"price_display":"13.55","price_state":"stated","total_value":27167.75,"total_display":"27,167.75","total_whole":"27,168","shares_owned_after":2978803.0,"shares_owned_after_display":"2,978,803","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-04-21","filed_date":"2016-04-25","scope":"insider","n_lines":2},{"id":8680085,"accession":"0001225208-15-020608","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-15-020608","line_url":"/filing/0001225208-15-020608#line-3","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001399028","owner_name":"Vivo Ventures V, LLC","owner_display_name":"Vivo Ventures V, LLC","owner_url":"/insider/0001399028","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9142.0,"shares_display":"9,142","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":15998.5,"total_display":"15,998.50","total_whole":"15,999","shares_owned_after":183767.0,"shares_owned_after_display":"183,767","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-09","filed_date":"2015-11-09","scope":"insider"},{"id":8680080,"accession":"0001225208-15-020608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-15-020608","line_url":"/filing/0001225208-15-020608#line-2","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001399028","owner_name":"Vivo Ventures V, LLC","owner_display_name":"Vivo Ventures V, LLC","owner_url":"/insider/0001399028","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":440.0,"shares_display":"440","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":814.0,"total_display":"814.00","total_whole":"814","shares_owned_after":192909.0,"shares_owned_after_display":"192,909","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-06","filed_date":"2015-11-09","scope":"insider"},{"id":8680074,"accession":"0001225208-15-020608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-15-020608","line_url":"/filing/0001225208-15-020608#line-1","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001399028","owner_name":"Vivo Ventures V, LLC","owner_display_name":"Vivo Ventures V, LLC","owner_url":"/insider/0001399028","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13111.0,"shares_display":"13,111","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":25042.01,"total_display":"25,042.01","total_whole":"25,042","shares_owned_after":193349.0,"shares_owned_after_display":"193,349","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-05","filed_date":"2015-11-09","scope":"insider"},{"id":8196727,"accession":"0000904454-15-000675","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000904454-15-000675","line_url":"/filing/0000904454-15-000675","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"Vivo Ventures V, LLC; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures V, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":463983.0,"shares_display":"463,983","price_per_share":15.45,"price_display":"15.45","price_state":"stated","total_value":7168537.35,"total_display":"7,168,537.35","total_whole":"7,168,537","shares_owned_after":2980785.0,"shares_owned_after_display":"2,980,785","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-04","filed_date":"2015-11-04","scope":"insider","n_lines":2},{"id":8196725,"accession":"0000904454-15-000675","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000904454-15-000675","line_url":"/filing/0000904454-15-000675","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"Vivo Ventures V, LLC; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures V, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58240.0,"shares_display":"58,240","price_per_share":16.32,"price_display":"16.32","price_state":"stated","total_value":950476.8,"total_display":"950,476.80","total_whole":"950,477","shares_owned_after":3439386.0,"shares_owned_after_display":"3,439,386","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-03","filed_date":"2015-11-04","scope":"insider","n_lines":2},{"id":8196723,"accession":"0000904454-15-000675","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-15-000675","line_url":"/filing/0000904454-15-000675","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"Vivo Ventures V, LLC; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures V, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80954.0,"shares_display":"80,954","price_per_share":16.8695,"price_display":"16.87","price_state":"stated","total_value":1365653.503,"total_display":"1,365,653.50","total_whole":"1,365,654","shares_owned_after":3496951.0,"shares_owned_after_display":"3,496,951","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-02","filed_date":"2015-11-04","scope":"insider","n_lines":2},{"id":6388739,"accession":"0001209191-14-070496","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-25","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1936843.0,"shares_display":"1,936,843","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2494520.0,"shares_owned_after_display":"2,494,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388737,"accession":"0001209191-14-070496","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-24","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":585437.0,"shares_display":"585,437","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":3490418.0,"shares_owned_after_display":"3,490,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388735,"accession":"0001209191-14-070496","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-23","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":348800.0,"shares_display":"348,800","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2900888.0,"shares_owned_after_display":"2,900,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388732,"accession":"0001209191-14-070496","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-22","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28028.0,"shares_display":"28,028","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2545277.0,"shares_owned_after_display":"2,545,277","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388730,"accession":"0001209191-14-070496","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-21","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22729.0,"shares_display":"22,729","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2517249.0,"shares_owned_after_display":"2,517,249","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388728,"accession":"0001209191-14-070496","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-20","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6870.0,"shares_display":"6,870","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":3497288.0,"shares_owned_after_display":"3,497,288","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388725,"accession":"0001209191-14-070496","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-19","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6689.0,"shares_display":"6,689","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2551966.0,"shares_owned_after_display":"2,551,966","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388723,"accession":"0001209191-14-070496","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-18","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4093.0,"shares_display":"4,093","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2904981.0,"shares_owned_after_display":"2,904,981","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388720,"accession":"0001209191-14-070496","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-17","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":122.0,"shares_display":"122","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2552088.0,"shares_owned_after_display":"2,552,088","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388693,"accession":"0001209191-14-070496","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-7","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"2014 Convertible Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1567878.63,"shares_display":"1,567,878.63","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388691,"accession":"0001209191-14-070496","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-6","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"2014 Convertible Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18400.64,"shares_display":"18,400.64","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388689,"accession":"0001209191-14-070496","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-5","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"2010/2012 Convertible Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9427594.51,"shares_display":"9,427,594.51","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388687,"accession":"0001209191-14-070496","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-4","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"2010/2012 Convertible Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136440.76,"shares_display":"136,440.76","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388685,"accession":"0001209191-14-070496","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-3","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"2010/2012 Convertible Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110642.23,"shares_display":"110,642.23","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6388683,"accession":"0001209191-14-070496","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-070496","line_url":"/filing/0001209191-14-070496#line-2","is_derivative":false,"issuer_cik":"0001227036","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227036","owner_cik":null,"owner_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP; Vivo Ventures Fund V, L.P.; Vivo Ventures V Affiliates Fund, L.P.; KUNG FRANK; BIOTECHNOLOGY DEVELOPMENT FUND IV LP; BIOASIA MANGEMENT LLC; BDF IV Annex Fund LP; BIOASIA INVESTMENTS IV LLC; Vivo Ventures V, LLC; Biotechnology Development Fund IV Affiliates LP","owner_display_name":"BIOTECHNOLOGY DEVELOPMENT FUND II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"2010/2012 Convertible Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32569.17,"shares_display":"32,569.17","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"}],"collapsed":true,"next_cursor":"2014-11-18|6388683","ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001484565","name":"SOLENO THERAPEUTICS INC","url":"/issuer/0001484565","role":"Ten percent owner","n_filings":11,"first_seen":"2014-11-20","last_seen":"2019-12-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001369786","name":"Sagent Pharmaceuticals, Inc.","url":"/issuer/0001369786","role":"Ten percent owner","n_filings":3,"first_seen":"2013-09-17","last_seen":"2016-04-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001262104","name":"MEI Pharma, Inc.","url":"/issuer/0001262104","role":"Ten percent owner","n_filings":6,"first_seen":"2013-05-20","last_seen":"2015-11-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001399028","retrieved_at":"2026-08-23T01:38:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}